78 related articles for article (PubMed ID: 18534061)
21. The expression of Toll-like receptors in patients with acute myeloid leukemia treated with induction chemotherapy.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Stefanko E; Dobrzyńska O; Poręba R; Kuliczkowski K
Leuk Res; 2015 Mar; 39(3):318-22. PubMed ID: 25624047
[TBL] [Abstract][Full Text] [Related]
22. Recurrent leukemia cutis in acute myeloblastic leukemia.
Girgis RE; Terebelo H; Maeda K
Henry Ford Hosp Med J; 1989; 37(2):76-8. PubMed ID: 2606734
[TBL] [Abstract][Full Text] [Related]
23. Serum proteomic spectral characteristics of acute myeloid leukemia and their clinical significance.
Zheng RJ; Wu RJ; Ma XD
Genet Mol Res; 2017 Apr; 16(2):. PubMed ID: 28407176
[TBL] [Abstract][Full Text] [Related]
24. The effect of short-course high-dose corticosteroid therapy on peripheral blood CD34+ progenitor cells in children with acute leukemia.
Cetin M; Hiçsönmez G; Tuncer AM; Kansu E; Canpynar H
Exp Hematol; 1996 Aug; 24(10):1191-4. PubMed ID: 8765493
[TBL] [Abstract][Full Text] [Related]
25. The Gln223Arg polymorphism of the leptin receptor gene and peripheral blood/bone marrow leptin level in leukemic children.
Wasik M; Górska E; Popko K; Pawelec K; Matysiak M; Demkow U
J Physiol Pharmacol; 2006 Sep; 57 Suppl 4():375-83. PubMed ID: 17072067
[TBL] [Abstract][Full Text] [Related]
26. Leukocytosis and circulating blasts in older adults with newly diagnosed acute myeloid leukemia: are they valuable factors for therapeutic decision-making?
Thomas X; Chelghoum Y; Cannas G; Elhamri M; Labussière H; Tigaud I; Ducastelle S; Nicolini F; Dumontet C; Michallet M
Clin Lymphoma Myeloma Leuk; 2011 Aug; 11(4):342-9. PubMed ID: 21816372
[TBL] [Abstract][Full Text] [Related]
27. Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia.
Arellano M; Pakkala S; Langston A; Tighiouart M; Pan L; Chen Z; Heffner LT; Lonial S; Winton E; Khoury HJ
Cancer; 2012 Nov; 118(21):5278-82. PubMed ID: 22517268
[TBL] [Abstract][Full Text] [Related]
28. Clinical and laboratory studies of 2-chlorodeoxyadenosine +/- cytosine arabinoside for relapsed or refractory acute myelogenous leukemia in adults.
Kornblau SM; Gandhi V; Andreeff HM; Beran M; Kantarjian HM; Koller CA; O'Brien S; Plunkett W; Estey E
Leukemia; 1996 Oct; 10(10):1563-9. PubMed ID: 8847890
[TBL] [Abstract][Full Text] [Related]
29. [Reactive histiocytosis during initial remission induction therapy for acute myeloblastic leukemia].
Okubo T; Asou N; Suzushima H; Matsumi S; Uchiba M; Okuno Y; Nishimura S; Takatsuki K; Kawano F
Rinsho Ketsueki; 1992 Dec; 33(12):1824-8. PubMed ID: 1479693
[TBL] [Abstract][Full Text] [Related]
30. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
Yavuz S; Paydas S; Disel U; Sahin B
Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
[TBL] [Abstract][Full Text] [Related]
31. Urinary excretion of proteolyzed alpha1-antitrypsin: specificity, quantitation, and relation to therapy response in patients with acute myeloid leukemia.
Dengler R; Plewan A; Münstermann U; Busch R; Eger G; Emmerich B
Clin Cancer Res; 1995 Feb; 1(2):199-205. PubMed ID: 9815974
[TBL] [Abstract][Full Text] [Related]
32. Residual disease monitoring in childhood acute myeloid leukemia by multiparameter flow cytometry: the MRD-AML-BFM Study Group.
; Langebrake C; Creutzig U; Dworzak M; Hrusak O; Mejstrikova E; Griesinger F; Zimmermann M; Reinhardt D
J Clin Oncol; 2006 Aug; 24(22):3686-92. PubMed ID: 16877738
[TBL] [Abstract][Full Text] [Related]
33. De novo acute myeloid leukemia with 20-29% blasts is less aggressive than acute myeloid leukemia with ≥30% blasts in older adults: a Bone Marrow Pathology Group study.
Hasserjian RP; Campigotto F; Klepeis V; Fu B; Wang SA; Bueso-Ramos C; Cascio MJ; Rogers HJ; Hsi ED; Soderquist C; Bagg A; Yan J; Ochs R; Orazi A; Moore F; Mahmoud A; George TI; Foucar K; Odem J; Booth C; Morice W; DeAngelo DJ; Steensma D; Stone RM; Neuberg D; Arber DA
Am J Hematol; 2014 Nov; 89(11):E193-9. PubMed ID: 25042343
[TBL] [Abstract][Full Text] [Related]
34. The combination of melphalan, cyclophosphamide and cytosine arabinoside as a conditioning regimen for autologous bone marrow transplantation for acute leukemia.
Wang C; Qiao Z; Yang L; Ma L; Zhang H; Zhang J
Chin Med J (Engl); 1996 Apr; 109(4):304-7. PubMed ID: 8758293
[TBL] [Abstract][Full Text] [Related]
35. Clinical significance of tissue polypeptide antigen in serum of acute nonlymphocytic leukemia.
Sadamori N; Mine M; Kawachi T; Hayashibara T; Itoyama T; Sasagawa I; Nakamura H; Tomonaga M
Leuk Res; 1995 Jun; 19(6):407-9. PubMed ID: 7596153
[TBL] [Abstract][Full Text] [Related]
36. ABCB1 gene polymorphisms are not associated with treatment outcome in elderly acute myeloid leukemia patients.
van der Holt B; Van den Heuvel-Eibrink MM; Van Schaik RH; van der Heiden IP; Wiemer EA; Vossebeld PJ; Löwenberg B; Sonneveld P
Clin Pharmacol Ther; 2006 Nov; 80(5):427-39. PubMed ID: 17112800
[TBL] [Abstract][Full Text] [Related]
37. Hematological and biochemical changes in acute leukemic patients after chemotherapy.
Rasheed A; Iqtidar A; Khan S
Zhongguo Yao Li Xue Bao; 1996 May; 17(3):207-8. PubMed ID: 9812735
[TBL] [Abstract][Full Text] [Related]
38. [A case of acute myeloblastic leukemia with Auer's bodies in mature neutrophils].
Sano M; Asano Y; Sugimoto H; Kodama H; Inoue U; Tomoyasu S; Tsuruoka N
Rinsho Ketsueki; 1984 Mar; 25(3):372-6. PubMed ID: 6590890
[No Abstract] [Full Text] [Related]
39. Expression of VEGF-C and its receptor VEGFR-3 in the bone marrow of patients with acute myeloid leukaemia.
Liersch R; Schliemann C; Bieker R; Hintelmann H; Buechner T; Berdel WE; Mesters RM
Leuk Res; 2008 Jun; 32(6):954-61. PubMed ID: 18006056
[TBL] [Abstract][Full Text] [Related]
40. Combinatorial molecular marker assays of WT1, survivin, and TERT at initial diagnosis of adult acute myeloid leukemia.
Kim HJ; Choi EJ; Sohn HJ; Park SH; Min WS; Kim TG
Eur J Haematol; 2013 Nov; 91(5):411-22. PubMed ID: 23826993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]